Integra Lifescience News Today

"Discover the biggest spine and orthopedic acquisitions of the last five years, from healthcare systems to medical device companies, as reported by Beckers."

YARDLEY, Pa., Jan. 15, 2024 /PRNewswire/ -- David Navazio, CEO and President, announced the appointment of several leadership executives to Gentells global executive team, and the opening of the companys

/PRNewswire/ -- David Navazio, CEO and President, announced the appointment of several leadership executives to Gentells global executive team, and the...

Welcome to the MassDevice Fast Five medtech news podcast. Here’s what you need to know for today, December 14, 2023.

PRINCETON, N.J., Oct. 25, 2023 -- Integra LifeSciences Holdings Corporation , a leading global medical technology company, today reported financial results for the third quarter ending September...

Artivion (NYSE:AORT – Get Free Report) and Integra LifeSciences (NASDAQ:IART – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, dividends, risk, valuation, earnings and institutional ownership. Risk and Volatility Artivion has a beta of 1.39, […]

The FDA says Integra Lifesciences has inadequately responded to violations that it found at the company's TEI Biosciences plant in Boston. 

PRINCETON, N.J., July 26, 2023 -- Integra LifeSciences Holdings Corporation , a leading global medical technology company, today reported financial results for the second quarter ending June 30,...

Major players in the orthopedic soft tissue repair market are Arthrex Inc., DePuy Synthes Inc., Stryker Corporation, Wright Medical Group N.V., Zimmer...

Thomson Reuters consensus EPS estimate of $3.47. The company issued revenue guidance of $2.1 billion-$2.2 billion, compared to the consensus revenue estimate of $2.15 billion. The company updated its FY2023 earnings and revenue guidance.